Sanford Consortium for Regenerative Medicine

Analysis

Sanford Consortium for Regenerative Medicine is a registered charity in United States, based in LA Jolla, CA. It received its IRS tax-exemption ruling in November 2007, 19 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Sanford Consortium for Regenerative Medicine reported income of $8.5m and spending of $9.2m, spending 109% of what it took in. Across the 5 years on record, from December 2019 to December 2023, income grew from $8.1m to $8.5m (+3.9%), an average of +1.0% a year. Over the whole period it spent 105% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Sanford Consortium for Regenerative Medicine sits at the 83rd percentile: it is larger than about 83% of them. Against every charity in United States with reported income it ranks in the 94th percentile, and in the 95th percentile within CA. Charities of a similar size with the same main cause include Inspira Health Network Inc ($8.5m), CHS Mobile Integrated Health Care Inc ($8.5m) and United Ambulance ($8.5m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 0.0% and program service revenue 98% of the total. Compensation of current officers, directors and key employees was $353k (3.8% of expenses). Other salaries and wages came to $50k. At year end it held assets of $85.0m against liabilities of $47.9m, net assets of $37.0m. It reported 2 employees.

Data notes from the register: Spending has exceeded income in each of the last three reported years, so the charity has been drawing on reserves or other funds.